Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (361)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Editorial (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (941)
  2. Center for Hematologic Malignancies (941)
  3. Department of Medicine (941)
  4. Hematologic Malignancies, Division of (941)
  5. Survivorship Research (473)
  6. CTCR Scholars (410)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (203)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (29)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (263)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (311)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (941)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR T cell therapy in early relapsed/refractory large B-cell lymphoma: Real world analysis from the Cell Therapy Consortium
    Meeting Abstract

    Rojek, A. E.; Ahmed, N.; Gomez Llobell, M.; Ahmed, S.; Hu, M.; Mead, M.; Chen, A.; Patel, V.; Brower, J.; Bachanova, V.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma
    Meeting Abstract

    Deschênes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A Proof-of-principle of split-course bridging radiotherapy (SC-BRT) prior to CAR T-cell therapies for relapsed or refractory B-cell lymphomas: A phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K. K.; Boardman, A. P.; Dahi, P. B.; Shah, G. L.; Scordo, M.; Park, J. H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Treatment patterns and predictors of survival after first line therapy in large B-cell lymphoma in a real-world US cohort
    Meeting Abstract

    McGuirk, J. P.; Fesen, M.; Ramsey, S. D.; Abou-Jawde, R.; Proli, A.; Hsu, H. L.; Patel, A. R.; Perales, M. A.; Adamson, B.; Fu, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patterns of immune reconstitution and their clinical significance in aggressive lymphoma treated with CAR-T therapy
    Meeting Abstract

    Luan, D. Y.; Dewolf, S.; Fei, T.; Raj, S. S.; Shah, G. L.; Lareau, C.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • NKTR-255 vs placebo to enhance complete responses and durability following CD19-directed CAR-T therapy in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)
    Meeting Abstract

    Ahmed, S.; Dipersio, J. F.; Essell, J. H.; Diefenbach, C. S.; Perales, M. A.; Castilla-Llorente, C.; Dahiya, S.; Chaudhry, S.; Xu, H.; Liu, Y.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Superiority of post-transplant cyclophosphamide-based graft versus host disease (GvHD) prophylaxis in patients 70 years and older: A BMT CTN 1703 post-hoc analysis
    Meeting Abstract

    Abedin, S.; Lian, Q. H.; Martens, M. J.; Malki, M. M. A.; Elmariah, H.; Gooptu, M.; Larkin, K. T.; Shaffer, B. C.; Loren, A. W.; Solh, M. M.; more...
    Blood (2024)

    Fulltext@MSK | Save